Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1

Ligtenberg, Marjolijn J L, Kuiper, Roland P, Chan, Tsun Leung, Goossens, Monique, Hebeda, Konnie M, Voorendt, Marsha, Lee, Tracy Y H, Bodmer, Danielle, Hoenselaar, Eveline, Hendriks-Cornelissen, Sandra J B, Tsui, Wai Yin, Kong, Chi Kwan, Brunner, Han G, van Kessel, Ad Geurts, Yuen, Siu Tsan, van Krieken, J Han J M, Leung, Suet Yi, Hoogerbrugge, Nicoline·2009·Nature Genetics
DOI 10.1038/ng.283

Cited by (827)

Items 301–400 of 827

  1. Updates in the field of hereditary nonpolyposis colorectal cancer
    Païvi Peltomäki, Alisa Petriina Olkinuora, Taina Tuulikki Nieminen · 2020 · Expert Review of Gastroenterology & Hepatology
  2. Next generation cytogenetics: comprehensive assessment of 48 leukemia genomes by genome imaging
    Kornelia Neveling, Tuomo Mantere, Susan Vermeulen, Michiel Oorsprong, Ronald van Beek, Ellen Kater‐Baats, Marc Pauper, Guillaume van de Zande, Dominique Smeets, Daniël Olde Weghuis et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  3. Molecular approach to genetic and epigenetic pathogenesis of early-onset colorectal cancer
    Gülçin Tezcan · 2016 · World Journal of Gastrointestinal Oncology
  4. Identification of Lynch Syndrome
    Jennifer K. Maratt, Elena M. Stoffel · 2021 · Gastrointestinal Endoscopy Clinics of North America
  5. Somatic mutations of the coding microsatellites within the beta-2-microglobulin gene in mismatch repair-deficient colorectal cancers and adenomas
    On behalf of investigators from the Melbourne Collaborative Cohort Study and the Australasian Colorectal Cancer Family Registry Cohort, Mark Clendenning, Alvin Huang, Harindra Jayasekara, Marie Lorans, Susan Preston, Neil O’Callaghan, Bernard J. Pope, Finlay Macrae, Ingrid Winship et al. · 2017 · Familial Cancer
  6. Candidate Biomarkers for Genetic and Clinicopathological Diagnosis of Endometrial Cancer
    Kouji Banno, Yuya Nogami, Iori Kisu, Megumi Yanokura, Kiyoko Umene, Kenta Masuda, Yusuke Kobayashi, Wataru Yamagami, Nobuyuki Susumu, Daisuke Aoki · 2013 · International Journal of Molecular Sciences
  7. No Difference in the Frequency of Locus-Specific Methylation in the Peripheral Blood DNA of Women Diagnosed with Breast Cancer and Age-Matched Controls
    Tomasz Kazimierz Wojdacz, Britta Boserup Thestrup, S. Cold, Jens Overgaard, Lise Lotte Hansen · 2011 · Future Oncology
  8. Defining the criteria for identifying constitutional epimutations
    Mathew A. Sloane, Robyn Lynne Ward, Luke B. Hesson · 2016 · Clinical Epigenetics
  9. Genotypic and Phenotypic Characteristics of Hereditary Colorectal Cancer
    Jin Cheon Kim, Walter Fred Bodmer · 2021 · Annals of Coloproctology
  10. A statistical method for single sample analysis of HumanMethylation450 array data: genome-wide methylation analysis of patients with imprinting disorders
    Faisal Ibne Rezwan, Louise E Docherty, Rebecca L. Poole, Gabrielle A. Lockett, Syed Hasan Arshad, John W. Holloway, I. Karen Temple, Deborah Mackay · 2015 · Clinical Epigenetics
  11. Germline Allele-Specific Expression of DAPK1 in Chronic Lymphocytic Leukemia
    Quan-Xiang Wei, Rainer Claus, Thomas Hielscher, Daniel Mertens, Aparna Raval, Christopher C. Oakes, Stephan M. Tanner, Albert de la Chapelle, John C. Byrd, Stephan Stilgenbauer et al. · 2013 · PLoS ONE
  12. Evaluation of predictive models in daily practice for the identification of patients with Lynch syndrome
    Christophe Trésallet, Antoine Brouquet, Catherine Julié, Alain Beauchet, Céline Vallot, F. Ménégaux, Emmanuel Mitry, François Radvanyi, Robert Malafosse, Philippe R Rougier et al. · 2011 · International Journal of Cancer
  13. Mismatch Repair Deficiency and Microsatellite Instability
    Sandra Schöniger, Josef Rüschoff · 2022 · Encyclopedia
  14. The Clinicopathological Features and Prognosis of Tumor MSI in East Asian Colorectal Cancer Patients Using NCI Panel
    Jianmin Zheng, Bangxing Huang, Xiu Nie, Yan Zhu, Ningning Han, Yan Li · 2018 · Future Oncology
  15. Screening for hereditary cancers in patients with endometrial cancer reveals a high frequency of germline mutations in cancer predisposition genes
    Wenjuan Tian, Rui Bi, Yu Ren, Hongsheng He, Shanfu Shi, Boer Shan, Wentao Yang, Qing Wang, Huaying Wang · 2019 · International Journal of Cancer
  16. Type 2 diabetes mellitus, blood cholesterol, triglyceride and colorectal cancer risk in Lynch syndrome
    S. Ghazaleh Dashti, Wing Yan Li, Daniel D. Buchanan, Mark Clendenning, Christophe Rosty, Ingrid Winship, Finlay Macrae, Graham G. Giles, Sheetal S. Hardikar, Xinwei Hua et al. · 2019 · British Journal of Cancer
  17. A Meta-Analysis of Obesity and Risk of Colorectal Cancer in Patients with Lynch Syndrome: The Impact of Sex and Genetics
    Matteo Lazzeroni, Federica Bellerba, Mariarosaria Calvello, Finlay Macrae, Aung Ko Win, Mark A. Jenkins, Davide Serrano, Monica Marabelli, Sara Cagnacci, Gianluca Tolva et al. · 2021 · Nutrients
  18. Lynch Syndrome: From Multidisciplinary Management to Precision Prevention
    Arianna Dal Buono, Alberto Puccini, Gianluca Franchellucci, Marco Airoldi, Michela Bartolini, Paolo Pietro Bianchi, Armando Santoro, Alessandro Repici, Cesare Hassan · 2024 · Cancers
  19. Epigenetics in Endometrial Carcinogenesis – part 2: Histone Modifications, Chromatin Remodeling and Noncoding RNAs
    Carla Bartosch, José Manuel Lopes, Cármen Jerónimo · 2017 · Epigenomics
  20. Germline and Tumor Sequencing as a Diagnostic Tool To Resolve Suspected Lynch Syndrome
    Bernard J. Pope, Mark Clendenning, Christophe Rosty, Khalid Mahmood, Peter Georgeson, Jihoon Eric Joo, Romy Walker, Ryan A. Hutchinson, Harindra Jayasekara, Sharelle L. Joseland et al. · 2020 · Journal of Molecular Diagnostics
  21. Pathologic Factors Associated with Prognosis after Adjuvant Chemotherapy in Stage II/III Microsatellite-Unstable Colorectal Cancers
    Jung Ho Kim, Jeong Mo Bae, Hyeon Jeong Oh, Hye Seung Lee, Gyeong Hoon Kang · 2015 · Journal of Pathology and Translational Medicine
  22. Cis-Acting Factors Causing Secondary Epimutations: Impact on the Risk for Cancer and Other Diseases
    Miguel Ruiz-de la Cruz, Aldo Hugo De La Cruz-Montoya, Ernesto Arturo Rojas-Jiménez, Héctor Martínez-Gregorio, Clara Estela Díaz Velásquez, Jimena Paredes de la Vega, Fidel de la Cruz Hernández‐Hernández, Felipe Vaca‐Paniagua · 2021 · Cancers
  23. A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndrome
    Romy Walker, Khalid Mahmood, Jihoon Eric Joo, Mark Clendenning, Peter Georgeson, Julia Como, Sharelle L. Joseland, Susan Preston, Yoland Catherine Antill, Rachel Austin et al. · 2023 · Journal of Translational Medicine
  24. Familial colorectal cancer
    Mei Sim Lung, Alison H. Trainer, Ian Campbell, Lara Rachel Lipton · 2015 · Internal Medicine Journal
  25. Practical genetics of colorectal cancer.
    Henry T. Lynch, Trudy G. Shaw · 2013 · PubMed
  26. Impact of genetic testing on endometrial cancer risk-reducing practices in women at risk for Lynch syndrome
    Matthew B.B. Yurgelun, Rowena C. Mercado, Margery Rosenblatt, Monica Dandapani, Wendy K. Kohlmann, Peggy G. Conrad, Amie M Blanco, Kristen Mahoney Shannon, Daniel C. Chung, Jonathan P. Terdiman et al. · 2012 · Gynecologic Oncology
  27. Mismatch repair protein immunohistochemistry: a useful population screening strategy for Lynch syndrome
    Eva Musulén, Carolina Sanz, Ana María Muñoz-Mármol, Aurelio Ariza · 2014 · Human Pathology
  28. Continuing difficulties in interpreting CNV data: lessons from a genome-wide CNV association study of Australian HNPCC/lynch syndrome patients
    Bente A. Talseth‐Palmer, Elizabeth G. Holliday, Tiffany‐Jane Evans, Mark McEvoy, John Attia, Desma M. Grice, Amy L Masson, Cliff J. Meldrum, Allan D. Spigelman, Rodney John Scott · 2013 · BMC Medical Genomics
  29. Etiology of familial breast cancer with undetected BRCA1 and BRCA2 mutations: clinical implications
    Eugenia Ch. Yiannakopoulou · 2013 · Cellular Oncology
  30. Clinical characteristics of Lynch-like cases collaterally classified by Lynch syndrome identification strategy using universal screening in endometrial cancer
    K Takahashi, Naoki Sato, Tae Sugawara, Aya Kato, Toshiharu Sato, Dai Shimizu, Daisuke Tamura, Masahiko Kito, Kenichi Makino, Hiromitsu Shirasawa et al. · 2017 · Gynecologic Oncology
  31. Comprehensive Constitutional Genetic and Epigenetic Characterization of Lynch-Like Individuals
    Estela Dámaso, Maribel González‐Acosta, Gardenia Vargas‐Parra, Matilde Navarro, Judith Balmañà, Teresa Ramón y Cajal, Noemí Tuset, Bryony A. Thompson, Fátima Marín, Anna Fernández et al. · 2020 · Cancers
  32. Assessment of DNA methylation at the interferon regulatory factor 5 (IRF5) promoter region in inflammatory bowel diseases
    Alfred Balasa, Grace N. Gathungu, Péter Kisfali, E O’Brian Smith, Judy H. Cho, Béla Melegh, Richárd Kellermayer · 2010 · International Journal of Colorectal Disease
  33. Genetics, Biomarkers, Hereditary Cancer Syndrome Diagnosis, Heterogeneity and Treatment: A Review
    Henry T. Lynch, Kristen M. Drescher, Joseph A. Knezetic, Stephen J. Lanspa · 2014 · Current Treatment Options in Oncology
  34. Dawning of the epigenetic era in hereditary cancer
    Megan Philippa Hitchins, Henry T. Lynch · 2014 · Clinical Genetics
  35. Understanding the Pathogenicity of Noncoding Mismatch Repair Gene Promoter Variants in Lynch Syndrome
    Qing Liu, Bryony A. Thompson, Robyn Lynne Ward, Luke B. Hesson, Mathew A. Sloane · 2016 · Human Mutation
  36. Heritable methylation marks associated with breast and prostate cancer risk
    Pierre‐Antoine Dugué, James G. Dowty, Jihoon Eric Joo, Ee Ming Wong, Enes Makalic, Daniel Francis Schmidt, Dallas R. English, John Llewelyn Hopper, John Pedersen, Gianluca Severi et al. · 2018 · The Prostate
  37. Australasian Gastrointestinal Pathology Society (AGPS) consensus guidelines for universal defective mismatch repair testing in colorectal carcinoma
    Masato Yozu, Priyanthi M. Kumarasinghe, Ian Brown, Anthony James Gill, Christophe Rosty · 2019 · Pathology
  38. Lynch Syndrome-Associated Cancers Beyond Colorectal Cancer
    Leah H. Biller, Siobhan A. Creedon, Margaret Klehm, Matthew B.B. Yurgelun · 2021 · Gastrointestinal Endoscopy Clinics of North America
  39. Risk assessment and genetic counseling for Lynch syndrome – Practice resource of the National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer
    Spring Holter, Michael J. Hall, Heather Hampel, Kory Jasperson, Sonia S. Kupfer, Joy Larsen Haidle, Maureen E. Mork, Selvi Palaniapppan, Leigha A. Senter, Elena M. Stoffel et al. · 2022 · Journal of Genetic Counseling
  40. Confirmation that somatic mutations of beta‐2 microglobulin correlate with a lack of recurrence in a subset of stage II mismatch repair deficient colorectal cancers from the QUASAR trial
    P Barrow, Susan D. Richman, Andrew J. Wallace, Kelly Handley, Gordon G. A. Hutchins, David James Kerr, Laura Magill, D. Gareth Evans, Richard G. Gray, Philip Quirke et al. · 2019 · Histopathology
  41. Importance of gastric cancer for the diagnosis and surveillance of Japanese Lynch syndrome patients
    The Japanese society for cancer of the colon and rectum (JSCCR), Tsuneo Ikenoue, Masami Arai, Chikashi Ishioka, Takeo Iwama∥, Satoshi Kaneko, Nagahide Matsubara, Yoshihiro Moriya, Tadashi Nomizu, Kokichi Sugano et al. · 2019 · Journal of Human Genetics
  42. Germline Structural Variations in Cancer Predisposition Genes
    Tímea Pócza, Vince Kornél Grolmusz, J. Papp, Henriett Butz, Attila Patócs, Anikó Bozsik · 2021 · Frontiers in Genetics
  43. Activation of cGAS-STING Pathway Is Associated with MSI-H Stage IV Colorectal Cancer
    Nenad Kunac, Marina Degoricija, Jelena Viculin, Jasminka Omerović, Janoš Terzić, Katarina Vilović, Jelena Korać-Prlić · 2022 · Cancers
  44. Genetic Testing Strategies in Newly Diagnosed Endometrial Cancer Patients Aimed at Reducing Morbidity or Mortality from Lynch Syndrome in the Index Case or Her Relatives
    Alison Stewart · 2013 · PLoS Currents
  45. Double heterozygosity for BRCA1 and hMLH1 gene mutations in a 46-year-old woman with five primary tumors
    Monica Pedroni, Carmela Di Gregorio, Laura Cortesi, Luca Reggiani Bonetti, G. Magnani, Maria Luisa Simone, Veronica Medici, Claudio Priore Oliva, Marco Marino, Maurizio Ponz de Leòn · 2013 · Techniques in Coloproctology
  46. Usefulness of epithelial cell adhesion molecule expression in the algorithmic approach to Lynch syndrome identification
    Eva Musulén, Ignacio Blanco, Cristina Carrato, María Teresa Fernández‐Figueras, Marta Pineda, Gabriel Capellá, Aurelio Ariza · 2012 · Human Pathology
  47. Epigenetic remodelling and dysregulation of DLGAP4 is linked with early-onset cerebellar ataxia
    Sheroy Minocherhomji, Claus Hansen, Hyung‐Goo Kim, Yuan Mang, Mads Bak, Per Guldberg, Nickolas Papadopoulos, Hans Eiberg, Gerald Dayebga Doh, Kjeld Møllgård et al. · 2014 · Human Molecular Genetics
  48. Inherited predisposition to colorectal cancer: towards a more complete picture
    Emma L. Short, Laura E. Thomas, Joanna J. Hurley, Sian Jose, Julian R. Sampson · 2015 · Journal of Medical Genetics
  49. Cytoplasmic MSH2 immunoreactivity in a patient with Lynch syndrome with an EPCAM–MSH2 fusion
    Shigeki Sekine, Reiko Ogawa, Shinya Saito, Mineko Ushiama, Dai Shida, Takeshi Nakajima, Hirokazu Taniguchi, Nobuyoshi Hiraoka, Teruhiko Yoshida, Kokichi Sugano · 2016 · Histopathology
  50. Duodenal tumor risk in Lynch syndrome
    Nassim Hammoudi, Marion Dhooge, Romain Coriat, Sarah Leblanc, Maximilien Barret, Benoît Bordaçahar, Frédéric Beuvon, Frédéric Prat, Fanny Maksimovic, Stanislas Chaussade · 2018 · Digestive and Liver Disease
  51. Differential Features of Microsatellite-Unstable Colorectal Carcinomas Depending on EPCAM Expression Status
    Jung Ho Kim, Jeong Mo Bae, Kyung-Ju Kim, Ye-Young Rhee, Young-Hoon Kim, Nam‐Yun Cho, Hye Seung Lee, Mee Soo Chang, Gyeong Hoon Kang · 2014 · Journal of Pathology and Translational Medicine
  52. When Tissue Is No Longer the Issue: Tissue-Agnostic Cancer Therapy Comes of Age
    Shiuh‐Wen Luoh, Keith T. Flaherty · 2018 · Annals of Internal Medicine
  53. Pancreatic ductal adenocarcinoma harboring microsatellite instability / DNA mismatch repair deficiency. Towards personalized medicine
    Renato Micelli Lupinacci, Jean‐Baptiste Bachet, Thierry André, Alex Duval, Magali Svrcek · 2018 · Surgical Oncology
  54. Cancer Predisposition Syndromes Associated With Pediatric High-Grade Gliomas
    Giulia Ceglie, Giada Del Baldo, Emanuele Agolini, Martina Rinelli, Antonella Cacchione, Francesca Del Bufalo, Maria Vinci, Roberto Carta, Luigi Boccuto, Evelina Miele et al. · 2020 · Frontiers in Pediatrics
  55. Evolutionary patterns of chromosomal instability and mismatch repair deficiency in proximal and distal colorectal cancer
    Monika M. Golas, Bastian Gunawan, Meliha Cakir, Silke Cameron, Christina Enders, Torsten Liersch, LASZLO FÜZESI, Bjoern Ole Sander · 2021 · Colorectal Disease
  56. A critical appraisal of clinical epigenetics
    Bernhard Horsthemke · 2022 · Clinical Epigenetics
  57. Microsatellite instability in noncolorectal and nonendometrial malignancies in patients with Lynch syndrome
    Lisa Elze, Rachel S. van der Post, Janet R. Vos, Arjen R. Mensenkamp, Mirjam S C de Hullu, Irıs D. Nagtegaal, Nicoline Hoogerbrugge, Richarda M. de Voer, Marjolijn J. L. Ligtenberg · 2023 · JNCI Journal of the National Cancer Institute
  58. Simplified identification of Lynch syndrome: A prospective, multicenter study
    Delphine Bonnet, Janick Sèlves, Christine Toulas, Marie Danjoux, Jean Pierre Duffas, Guillaume Portier, Sylvain Kirzin, Laurent Ghouti, Nicolas Carrère, Bertrand Suc et al. · 2012 · Digestive and Liver Disease
  59. Epigenetic Epidemiology for Cancer Risk: Harnessing Germline Epigenetic Variation
    Kevin Brennan, James M. Flanagan · 2012 · Methods in molecular biology
  60. CD3Zhypermethylation is associated with severe clinical manifestations in systemic lupus erythematosus and reduces CD3ζ-chain expression in T cells
    Kyeong‐Man Hong, Hyun-Kyoung Kim, Seong-Yeol Park, Shiv Poojan, Mi Kyung Kim, Joohon Sung, Betty P. Tsao, Jennifer M. Grossman, Ornella J. Rullo, Jennifer M. P. Woo et al. · 2016 · Lara D. Veeken
  61. Advances in Identification of Susceptibility Gene Defects of Hereditary Colorectal Cancer
    Qiang Liu, Yue‐Qiu Tan · 2019 · Journal of Cancer
  62. p53, Cyclin-D1, β-catenin, APC and c-myc in Tumor Tissue from Colorectal and Gastric Cancer Patients with Suspected Lynch Syndrome by the Bethesda Criteria
    Tais Fernanda Santos Marculino, Célia Aparecida Marques Pimenta, Ricardo Artigiani Neto, Paula Midori Castelo, Marcelo de Souza Silva, Nora Manoukian Forones, Celina Tizuko Fujiyama Oshima · 2020 · Asian Pacific Journal of Cancer Prevention
  63. Clinical characteristics of pancreatic and biliary tract cancers in Lynch syndrome: A retrospective analysis from the Finnish National Lynch Syndrome Research Registry
    Kristina Zalevskaja, Jukka‐Pekka Mecklin, Toni T. Seppälä · 2023 · Frontiers in Oncology
  64. Seryl-tRNA synthetase promotes translational readthrough by mRNA binding and involvement of the selenocysteine incorporation machinery
    Ze Liu, Justin Qiyun Wang, Yi Shi, Brian A. Yee, Markus Terrey, Qian Zhang, Jenq‐Chang Lee, Kuo‐I Lin, Andrew H.‐J. Wang, Susan L. Ackerman et al. · 2023 · Nucleic Acids Research
  65. Exploring the Molecular Interaction of PCOS and Endometrial Carcinoma through Novel Hyperparameter-Optimized Ensemble Clustering Approaches
    Pınar Karadayı Ataş · 2024 · Mathematics
  66. Mismatch Repair Deficiency Assessment by Immunohistochemistry: For Lynch Syndrome Screening and Beyond
    Hui‐Li Wong, Michael Christie, Lucy Gately, Jeanne Tie, Belinda Lee, Christine Semira, Sheau Wen Lok, Rachel Wong, Peter Gibbs · 2018 · Future Oncology
  67. Mismatch repair-based stratification for immune checkpoint blockade therapy.
    Lihong Zhang, Yang Peng, Guang Peng · 2018 · Europe PMC (PubMed Central)
  68. Muir–Torre syndrome or phenocopy? The value of the immunohistochemical expression of mismatch repair proteins in sebaceous tumors of immunocompromised patients
    Giovanni Ponti, Giovanni Pellacani, Cristel Ruini, Antonio Percesepe, Caterina Longo, Victor Desmond Mandel, Francesca Crucianelli, Greta Gorelli, Aldo Tomasi · 2014 · Familial Cancer
  69. Detection of allelic imbalance in MLH1 expression by pyrosequencing serves as a tool for the identification of germline defects in Lynch syndrome
    Chau‐To Kwok, Robyn Lynne Ward, Nicholas John Hawkins, Megan Philippa Hitchins · 2010 · Familial Cancer
  70. Epigenetic Therapies in Melanoma—Targeting DNA Methylation and Histone Modification
    Adrian Bogdan Țigu, Andrei Ivancuta, Andrada Uhl, Alexandru Cristian Sabo, Mădălina Nistor, Ximena Maria Mureșan, Diana Cenariu, Tanase Timis, Doru Mihai Diculescu, Diana Gulei · 2025 · Biomedicines
  71. EpCAM is up-regulated by EGF via ERK1/2 signaling and suppresses human epithelial ovarian cancer cell migration
    Qianlan Fan, Jung‐Chien Cheng, Xin Yao Qiu, Hsun‐Ming Chang, Peter C. K. Leung · 2015 · Biochemical and Biophysical Research Communications
  72. Pancreatic intraductal papillary mucinous neoplasm in a patient with Lynch syndrome
    Meghan Rose Flanagan · 2015 · World Journal of Gastroenterology
  73. Low expression of MSH2 DNA repair protein is associated with poor prognosis in head and neck squamous cell carcinoma
    Camila Santos Pereira, Marcos Vinícius Macêdo de Oliveira, Lucas Oliveira Barros, Gabriela Alencar Bandeira, Sérgio Henrique Sousa Santos, John R. Basile, André Luiz Sena Guimarães, Alfredo Maurício Batista de Paula · 2013 · Journal of Applied Oral Science
  74. Advances in Hereditary Colorectal and Pancreatic Cancers
    Meghan L. Underhill-Blazey, Katharine A. Germansky, Matthew B.B. Yurgelun · 2016 · Clinical Therapeutics
  75. Cancer predisposition syndromes: lessons for truly precision medicine
    Mark A. Glaire, Matthew Brown, David N. Church, Ian P.M. Tomlinson · 2016 · The Journal of Pathology
  76. A Highly Sensitive Pan-Cancer Test for Microsatellite Instability
    Jeffery W. Bacher, Eshwar B. Udho, Ethan E. Strauss, Irina Vyazunova, Steve Gallinger, Daniel D. Buchanan, Rish K. Pai, Allyson S. Templeton, Douglas R. Storts, James R. Eshleman et al. · 2023 · Journal of Molecular Diagnostics
  77. Analysis of Epigenetic Modifications of DNA in Human Cells
    Lasse S. Kristensen, Marianne Bach Treppendahl, Kirsten Grønbæk · 2013 · Current Protocols in Human Genetics
  78. Hereditary gastrointestinal cancer syndromes.
    Henry T. Lynch, Jane F. Lynch, Trudy G. Shaw · 2011 · PubMed Central
  79. Dietary B vitamin and methionine intake and MTHFR C677T genotype on risk of colorectal tumors in Lynch syndrome: the GEOLynch cohort study
    Audrey Y. Jung, Fränzel J.B. van Duijnhoven, Fokko M. Nagengast, Akke Botma, Renate C Heine-Bröring, Jan H. Kleibeuker, Hans F. A. Vasen, Jan L. Harryvan, Renate M. Winkels, Ellen Kampman · 2014 · Cancer Causes & Control
  80. G protein subunit α q regulates gastric cancer growth via the p53/p21 and MEK/ERK pathways
    Yizhuo Wang, Huijie Xiao, Haitao Wu, Yao Cheng, Hua He, Chang Wang, Wei Li · 2017 · Oncology Reports
  81. Candidate Gene Discovery in Hereditary Colorectal Cancer and Polyposis Syndromes–Considerations for Future Studies
    Iris te Paske, Marjolijn J. L. Ligtenberg, Nicoline Hoogerbrugge, Richarda M. de Voer · 2020 · International Journal of Molecular Sciences
  82. Application of targeted nanopore sequencing for the screening and determination of structural variants in patients with Lynch syndrome
    Kiyoshi Yamaguchi, Rika Kasajima, Kiyoko Takane, Seira Hatakeyama, Eigo Shimizu, Rui Yamaguchi, Kotoe Katayama, Masami Arai, Chikashi Ishioka, Takeo Iwama∥ et al. · 2021 · Journal of Human Genetics
  83. EPCAM deletions, Lynch syndrome, and cancer risk
    Henry T. Lynch, Jane F. Lynch, Carrie Snyder, Douglas L. Riegert‐Johnson · 2010 · The Lancet Oncology
  84. Gender-Specific Aspects of Lynch Syndrome and Familial Adenomatous Polyposis
    Ralph Schneider, Claudia Schneider, Christian Jakobeit, Alois Fürst, Gabriela Möslein · 2014 · Visceral Medicine
  85. Identification of MSH2 inversion of exons 1–7 in clinical evaluation of families with suspected Lynch syndrome
    Maureen E. Mork, Andrea Rodríguez, Melissa W. Taggart, Miguel A. Rodrı́guez-Bigas, Patrick M. Lynch, Sarah A. Bannon, Y. Nancy You, Eduardo Vilar · 2016 · Familial Cancer
  86. Increasing awareness and knowledge of lifestyle recommendations for cancer prevention in Lynch syndrome carriers: Randomized controlled trial
    Alina Vrieling, Annemiek Visser, Meeke Hoedjes, M. Hurks, Encarna B. Gómez-García, Nicoline Hoogerbrugge, Ellen Kampman · 2017 · Clinical Genetics
  87. KRAS Signaling Pathway Alterations in Microsatellite Unstable Gastrointestinal Cancers
    Sérgia Velho, Giovanni Corso, Carla Oliveíra, Raquel Seruca · 2010 · Advances in cancer research
  88. Maintenance of epigenetic information: a noncoding RNA perspective
    Tanmoy Mondal, Chandrasekhar Kanduri · 2013 · Chromosome Research
  89. Intratumoural pks Escherichia coli is associated with risk of metachronous colorectal cancer and adenoma development in people with Lynch syndrome
    Yen Lin Chu, Peter Georgeson, Mark Clendenning, Khalid Mahmood, Romy Walker, Julia Como, Sharelle L. Joseland, Susan Preston, Toni Rice, Brigid Mary Lynch et al. · 2025 · EBioMedicine
  90. Impact of colonoscopic screening in Familial Colorectal Cancer Type X
    Elizabeth Hatfield, Jane S. Green, Michael O. Woods, Geoff M. Warden, Patrick S. Parfrey · 2018 · Molecular Genetics & Genomic Medicine
  91. Genetic insights: High germline variant rate in an indigenous African cohort with early-onset colorectal cancer
    Safiye Yildiz, Takudzwa N. Musarurwa, Ursula Algar, Ramadhani Chambuso, George Rebello, Paul A. Goldberg, Raj Ramesar · 2023 · Frontiers in Oncology
  92. A 39 kb structural variant causing Lynch Syndrome detected by optical genome mapping and nanopore sequencing
    P. M. Bjørnstad, Ragnhild Aaløkken, June Åsheim, Arvind Y. M. Sundaram, Caroline Nangota Felde, Gina Henriette Østby, Marianne Dalland, Wenche Sjursen, Christian Carrizosa, Magnus Dehli Vigeland et al. · 2023 · European Journal of Human Genetics
  93. Expanding the genetic basis of copy number variation in familial breast cancer
    Amy L Masson, Bente A. Talseth‐Palmer, Tiffany‐Jane Evans, Desma M. Grice, Garry N. Hannan, Rodney John Scott · 2014 · Hereditary Cancer in Clinical Practice
  94. Classification of genetic variants in genes associated with Lynch syndrome using a clinical history weighting algorithm
    Brian Morris, Elisha Hughes, Eric Rosenthal, Alexander Gutin, Karla R. Bowles · 2016 · BMC Genetics
  95. Epimutation in inherited metabolic disorders: the influence of aberrant transcription in adjacent genes
    Jean‐Louis Guéant, Youssef Siblini, Céline Chéry, Guillaume Schmitt, Rosa‐Maria Guéant‐Rodriguez, David Coelho, David Watkins, David S. Rosenblatt, Abderrahim Oussalah · 2022 · Human Genetics
  96. Occurrence of variants of unknown clinical significance in genetic testing for hereditary breast and ovarian cancer syndrome and Lynch syndrome: a literature review and analytical observational retrospective cohort study
    Felicia Adam, Muriel Fluri, Amina Scherz, Manuela Rabaglio · 2023 · BMC Medical Genomics
  97. Lynch Syndrome: History, Causes, Diagnosis, Treatment and Prevention (CAPP2 Trial)
    John Burn, John Cummings Mathers, David Timothy Bishop · 2012 · Digestive Diseases
  98. Hereditary cancer syndromes as model systems for chemopreventive agent development
    Farzana L. Walcott, Jigar Patel, Ronald A. Lubet, Luz M. Rodriguez, Kathleen A. Calzone · 2015 · Seminars in Oncology
  99. Genetic anticipation in Swedish Lynch syndrome families
    Jenny von Salomé, Philip S. Boonstra, Masoud Karimi, Gustav Silander, Marie Stenmark‐Askmalm, Samuel Gebré‐Medhin, Christos Aravidis, Mef Christina Nilbert, Annika Lindblom, Kristina Lagerstedt‐Robinson · 2017 · PLoS Genetics
  100. Historical review of Lynch syndrome
    Andrew I. Wolf, Adam H. Buchanan, Linda M. Farkas · 2013 · Journal of Coloproctology